Evidence map›Paper›PMID 26278724›Full record

ArticleAIDS care2016

On the front line of HIV virological monitoring: barriers and facilitators from a provider perspective in resource-limited settings.

S E Rutstein, C E Golin, S B Wheeler, D Kamwendo, M C Hosseinipour, M Weinberger, W C Miller, A K Biddle, A Soko, M Mkandawire and 4 more

Registry-linked trialAbstract read
In one paragraph

Article in AIDS care, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03553693 (Optimizing HIV Viral Load Monitoring and Outcomes for High Risk Populations), which is not on this map. Cited by 34 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03553693 nacompletednot on this mapstarted 2018, after this paper: background citation

Optimizing HIV Viral Load Monitoring and Outcomes for High Risk Populations

TypeinterventionalSponsorUniversity of California, San FranciscoRan2018 to 2020Enrolled2,443ConditionsHIVArmsRAPID-VL study intervention
3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

S E Rutsteina Department of Health Policy and Management , University of North Carolina at Chapel Hill , Chapel Hill , NC , USA.
C E Golinc Department of Health Behavior , University of North Carolina at Chapel Hill , Chapel Hill , NC , USA.
S B Wheelera Department of Health Policy and Management , University of North Carolina at Chapel Hill , Chapel Hill , NC , USA.
D Kamwendod UNC Project , Lilongwe , Malawi.
M C Hosseinipourb Department of Medicine , University of North Carolina at Chapel Hill , Chapel Hill , NC , USA.
M Weinbergera Department of Health Policy and Management , University of North Carolina at Chapel Hill , Chapel Hill , NC , USA.
W C Millerb Department of Medicine , University of North Carolina at Chapel Hill , Chapel Hill , NC , USA.
A K Biddlea Department of Health Policy and Management , University of North Carolina at Chapel Hill , Chapel Hill , NC , USA.
A Sokod UNC Project , Lilongwe , Malawi.
M Mkandawiref School of Public Health , Loma Linda University , Loma Linda , CA , USA.
R Mwendag Ministry of Health , Lilongwe , Malawi.
A Sarrh Centers for Disease Control , Lilongwe , Malawi.
S Guptah Centers for Disease Control , Lilongwe , Malawi.
R Matayaf School of Public Health , Loma Linda University , Loma Linda , CA , USA.

Funding

Virology, Immunology, and Microbiology CoreP30AI050410 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI DAVID M. MARGOLIS · 2001 to 2026
$76.9M
MEDICAL SCIENTIST TRAINING PROGRAMT32GM008719 · NIGMS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI DARVILLE, TONI, DESHMUKH, MOHANISH P · 1999 to 2023
$15.1M
SUPPORTING THE SCALE-UP HIGH QUALITY HIV CARE AND TREATMENT PROGRAMS IN MALAWI U2GPS001965 · PS · UNIVERSITY OF MALAWI · PI KAMIZA, DR. STEVE · 2009 to 2014
$12.9M
Optimizing HIV Therapy: virological monitoring, adherence & cost-effectivenessF30MH098731 · NIMH · UNIV OF NORTH CAROLINA CHAPEL HILL · PI RUTSTEIN, SARAH E. · 2012 to 2016
$201k
NCHHSTP CDC HHS U2G PS001965NIAID NIH HHS P30 AI050410NIAID NIH HHS P30AI50410NIGMS NIH HHS T32 GM008719NIMH NIH HHS F30 MH098731NIMH NIH HHS F30 MH098731-01PHS HHS MW.10.1433
6 · The paper itself

Abstract

Scale-up of viral load (VL) monitoring for HIV-infected patients on antiretroviral therapy (ART) is a priority in many resource-limited settings, and ART providers are critical to effective program implementation. We explored provider-perceived barriers and facilitators of VL monitoring. We interviewed all providers (n = 17) engaged in a public health evaluation of dried blood spots for VL monitoring at five ART clinics in Malawi. All ART clinics were housed within district hospitals. We grouped themes at patient, provider, facility, system, and policy levels. Providers emphasized their desire for improved ART monitoring strategies, and frustration in response to restrictive policies for determining which patients were eligible to receive VL monitoring. Although many providers pled for expansion of monitoring to include all persons on ART, regardless of time on ART, the most salient provider-perceived barrier to VL monitoring implementation was the pressure of work associated with monitoring activities. The work burden was exacerbated by inefficient data management systems, highlighting a critical interaction between provider-, facility-, and system-level factors. Lack of integration between laboratory and clinical systems complicated the process for alerting providers when results were available, and these communication gaps were intensified by poor facility connectivity. Centralized second-line ART distribution was also noted as a barrier: providers reported that the time and expenses required for patients to collect second-line ART frequently obstructed referral. However, provider empowerment emerged as an unexpected facilitator of VL monitoring. For many providers, this was the first time they used an objective marker of ART response to guide clinical management. Providers' knowledge of a patient's virological status increased confidence in adherence counseling and clinical decision-making. Results from our study provide unique insight into provider perceptions of VL monitoring and indicate the importance of policies responsive to individual and environmental challenges of VL monitoring program implementation. Findings may inform scale-up by helping policy-makers identify strategies to improve feasibility and sustainability of VL monitoring.

Indexed as

Health Care CostsHealth ResourcesAdultAnti-HIV AgentsAntiretroviral Therapy, Highly ActiveDrug MonitoringFemaleHealth PersonnelHIV InfectionsHumansInterviews as TopicMalawiMalePerceptionViral LoadWorkloadAnti-HIV AgentsHIVprovider perceptionsresource-limited settingsviral load monitoring

Identifiers

PMID26278724
PMCPMC4834050

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.